| Active substance |
Cabergoline |
| Also known as |
Cabaser, Dostinex |
| Blood pressure |
May cause hypotension (lower blood pressure) |
| Chemical name |
1-[(6-allylergolin-8ОІ-yl)-carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea |
| Dosage (medical) |
Typically 0.25 mg to 1 mg twice a week for hyperprolactinemia |
| Dosage (sports) |
Not officially recommended for sports uses, typically around 0.25 mg to 0.5 mg per week when used |
| Effects |
Decreases prolactin levels, can potentially enhance mood and libido |
| Formula |
C26H37N5O2 |
| Half-life |
63 to 68 hours |
| Hepatotoxicity |
Low risk, but liver function monitoring is advised for prolonged use |
| Lab Test |
Blood prolactin levels |
| Main action |
Dopamine D2 receptor agonist |
| Side effects |
Nausea, headache, dizziness, orthostatic hypotension, constipation, fatigue, heart valve issues in higher doses |
| Storage conditions |
Store at room temperature, protect from light and moisture |
| Substance class |
Ergoline derivative |
| Trade name |
Dostinex, Cabaser |
| Use in sports |
Primarily used to reduce prolactin-related side effects of anabolic steroids |
| Water Retention |
No significant impact on water retention |
| Active ingredient, mg |
0,5 |
| Release form |
Pills |
| Manufacturer |
Balkan Pharmaceuticals |
| Packing |
Pack (100 pills) |
